Cadila Healthcare informs about press release

10 Nov 2017 Evaluate

Cadila Healthcare has informed about a Press Release dated November 10, 2017 titled ‘Zydus announces regulatory approval of Lipaglyn (Saroglitazar Magnesium) in Mexico’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

920.90 -10.55 (-1.13%)
08-Dec-2025 15:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×